Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-12 5:20 pm Purchase | 13G | OCULAR THERAPEUTIX INC OCUL | Opaleye Management Inc. | 6,510,000 8.65% | 1,384,000 (+27.00%) | View |
| 2021-01-08 5:28 pm Purchase | 13G | FS DEV CORP COM FSDC | Opaleye Management Inc. | 668,400 5.34% | 668,400 (New Position) | View |
| 2020-09-25 5:20 pm Sale | 13D | ARTARA THERAPEUTICS INC TARA | Opaleye Management Inc. | 2,508,472 23.86% | -2,527,538 (-50.19%) | View |
| 2020-09-18 6:48 pm Purchase | 13G | INFINITY PHARMACEUTICALS INC C INFI | Opaleye Management Inc. | 3,000,400 5.1% | 3,000,400 (New Position) | View |
| 2020-08-31 9:40 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Opaleye Management Inc. | 1,718,346 13.03% | 1,718,346 (New Position) | View |
| 2020-08-28 5:15 pm Purchase | 13G | CARDIFF ONCOLOGY INC CRDF | Opaleye Management Inc. | 1,248,000 5.37% | 1,248,000 (New Position) | View |
| 2020-08-21 5:15 pm Purchase | 13G | ADAMAS PHARMACEUTICALS INC ADMS | Opaleye Management Inc. | 1,426,000 5.04% | 1,426,000 (New Position) | View |
| 2020-08-21 4:30 pm Purchase | 13G | CHIMERIX INC CMRX | Opaleye Management Inc. | 3,142,900 5.14% | 3,142,900 (New Position) | View |
| 2020-05-26 11:09 am Sale | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 2,625,000 10.27% | -1,015,000 (-27.88%) | View |
| 2020-04-06 7:20 pm Purchase | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 3,640,000 17.77% | 1,300,000 (+55.56%) | View |
| 2020-03-30 5:00 pm Purchase | 13G | SEMLER SCIENTIFIC INC SMLR | Opaleye Management Inc. | 333,500 5.1% | 333,500 (New Position) | View |
| 2020-02-21 4:30 pm Purchase | 13G | CIDARA THERAPEUTICS INC CDTX | Opaleye Management Inc. | 2,327,000 5.55% | 917,000 (+65.04%) | View |
| 2020-02-14 4:30 pm Purchase | 13G | STEREOTAXIS INC STXS | Opaleye Management Inc. | 4,112,500 6.16% | 47,400 (+1.17%) | View |
| 2020-02-14 4:30 pm Purchase | 13G | EDAP TMS S.A. SPONS ADR EDAP | Opaleye Management Inc. | 1,785,000 6.16% | 264,500 (+17.40%) | View |
| 2020-02-14 4:30 pm Purchase | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 2,340,000 9.3% | 870,544 (+59.24%) | View |
| 2020-02-14 4:30 pm Purchase | 13G | CERECOR INC CERC | Opaleye Management Inc. | 2,190,674 4.18% | 5,138 (+0.24%) | View |
| 2020-02-14 4:30 pm Purchase | 13G | AVENUE THERAPEUTICS INC NE ATXI | Opaleye Management Inc. | 1,035,000 6.21% | 485,000 (+88.18%) | View |
| 2020-02-14 4:30 pm Purchase | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 1,469,456 8.25% | 587,778 (+66.67%) | View |
| 2020-02-14 4:30 pm Purchase | 13G | FORTRESS BIOTECH INC FBIO | Opaleye Management Inc. | 3,825,100 5.4% | 7,800 (+0.20%) | View |
| 2020-02-14 4:30 pm Sale | 13G | CIDARA THERAPEUTICS INC CDTX | Opaleye Management Inc. | 1,410,000 4% | -1,230,000 (-46.59%) | View |